The present invention relates to VEGFR inhibitors and their use in the treatment of cell proliferative diseases such as cancer. The said derivatives may further act as HDAC inhibitors.
-
Page/Page column 55
(2009/04/25)
More Articles about upstream products of 1012060-44-4